BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $1.6M invested in ProShares UltraShort NASDAQ Biotechnology in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$26K
2
+$20K
3
+$13.3K

Top Sellers

1
-$362K
2
-$284K
3
-$256K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$230K
5
TRCT
Tower Research Capital (TRC)
New York
-$27.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$637K
2
$556K
3
$261K
4
$98K
5
$26K
6
$20K
7
$2K
8
–
9
–
10
–
11
–